Joseph McLaughlin, MD
Board Certifications: Hematology, Internal Medicine and Medical Oncology
Languages: English
Locations: Manchester, CT
Call Manchester, CT: (860) 646-0670
Joseph McLaughlin, MD, is a medical oncologist serving patients at Regional Cancer Care Associates (RCCA) in Manchester, Connecticut. He is board-certified in both hematology and medical oncology, highly skilled in addressing a range of cancer types and non-malignant hematology conditions. He treats every patient as if they were his own family, working tirelessly to make sure they obtain the best outcomes possible from care. Schedule an appointment with Dr. McLaughlin today.
Like many RCCA physicians, Dr. McLaughlin has expertise in handling a variety of cancer types including breast cancer, colon cancer, lung cancer, and prostate cancer. He also treats malignant and benign blood conditions. His care approach prioritizes the most advanced treatments, including:
In addition to the above, Dr. McLaughlin also gives his patients access to clinical trials. These are advanced research trials where patients can benefit from new treatments that are still in development, helping physicians prepare these modalities for wide availability. All trials are performed with strict adherence to regulations and with the patient’s fully informed consent.
Academic Appointments and Achievements
Education
Medical school: Thomas Jefferson University School of Medicine
Residency: Thomas Jefferson University Hospital
Fellowship: Yale-New Haven Hospital, Oncology
Board certifications: Internal Medicine, Hematology, and Oncology
About Joseph McLaughlin, MD
Dr. McLaughlin was drawn to the oncology field by his personal connections with it. He unfortunately lost multiple family members to cancer and hematological disorders. These losses were difficult, instilling in him an appreciation for everything cancer care requires. They also gave him a drive to improve cancer treatments, in hopes of creating better outcomes for future patients.
“I strive to treat every patient as if they were my own family,” says Dr. McLaughlin. He works tirelessly on behalf of his patients and their families, helping them obtain the best outcomes possible.
Part of this commitment is in research. Though cancer is often life-changing, recent advances in oncology are leading to better outcomes. Immunotherapy, targeted therapies, and personalized medicine have transformed how oncologists treat cancer, leading to remission for diagnoses that were previously incurable and improving survival in cases where a cure is still not possible. This provides hope where there was none before.
Of course, there is still progress left to be made. For this reason, Dr. McLaughlin is active in cancer research. He pursues new treatments and innovations to create better futures for patients with cancer, one study or clinical trial at a time.
Dr. McLaughlin also understands how difficult healthcare systems can be to navigate. When a cancer diagnosis and treatment are already difficult, this challenge only creates an additional burden. He shares this burden by assisting patients with different aspects of their care. “Put my patients and their families’ interests above all else,” he says. “We are all in this together, as a family; and as a family, I will continue to provide individualized, compassionate care.”
Locations
Dr. McLaughlin treats patients at RCCA in Manchester, CT.
We are here for you
For more information or to schedule an appointment, call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.